Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient Derived Organoid”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04768270
What this trial is testing

The Culture of Ovarian Cancer Organoids and Drug Screening

Who this might be right for
Ovarian Cancer
Chongqing University Cancer Hospital 30
Not applicableUnknownNCT03990675
What this trial is testing

Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids

Who this might be right for
Pancreas Cancer
Technical University of Munich 50
Not applicableUnknownNCT03971812
What this trial is testing

Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma

Who this might be right for
Glioma
Assistance Publique Hopitaux De Marseille 20
Not applicableUnknownNCT04279509
What this trial is testing

Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)

Who this might be right for
OrganoidsHNSCCEpithelial Ovarian Cancer+1 more
National University Hospital, Singapore 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07351591
What this trial is testing

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract Cancer(BTC)
Eastern Hepatobiliary Surgery Hospital 88
Not applicableNot Yet RecruitingNCT07516626
What this trial is testing

Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer (LABC)
Atlas University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07214649
What this trial is testing

Organoids for Bile Leaks

Who this might be right for
Biliary Anastomosis Complication
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 25
Not applicableLooking for participantsNCT05038358
What this trial is testing

Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms

Who this might be right for
Primary TumorColon Tumor
University Hospital, Grenoble 60
Not applicableUnknownNCT03453307
What this trial is testing

Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients

Who this might be right for
NSCLC
K2 Oncology, Inc. 100
Not applicableUnknownNCT05304741
What this trial is testing

The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening

Who this might be right for
Colorectal Cancer
Chongqing University Cancer Hospital 30
Not applicableStudy completedNCT05351983
What this trial is testing

Patient-derived Organoids Drug Screen in Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreas Adenocarcinoma+3 more
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME 60
Not applicableNot Yet RecruitingNCT06615830
What this trial is testing

Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.

Who this might be right for
Pancreas NeoplasmsPancreatic NeoplasmsPancreatic Cancer Metastatic+1 more
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME 185
Testing effectiveness (Phase 2)Ended earlyNCT06405230
What this trial is testing

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 2
Not applicableLooking for participantsNCT06959173
What this trial is testing

Organoid-guided Personalized Treatment of Pleural Effusion

Who this might be right for
Lung Cancer
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06102824
What this trial is testing

Organoid-based Functional Precision Therapy for Advanced Breast Cancer

Who this might be right for
HER2-negative Breast CancerAdvanced Breast Cancer
Guangdong Provincial People's Hospital 252
Not applicableLooking for participantsNCT06085404
What this trial is testing

Patients Derived Organoids in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 48
Not applicableLooking for participantsNCT06459791
What this trial is testing

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)

Who this might be right for
Metastatic Breast Cancer
Institut Curie 110
Not applicableUnknownNCT05290961
What this trial is testing

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

Who this might be right for
Ovarian Neoplasms
Chongqing University Cancer Hospital 30
Not applicableLooking for participantsNCT07683845
What this trial is testing

Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Beijing Daxiang Biotech Co., Ltd 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227065
What this trial is testing

Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive Bladder CancerLow Grade
Hospital Centre Biel/Bienne 28
Next Page